|
|
||||||||||||||||||||
HIV Treatment News |
|
|||||||||||||||||||
Psychiatric/Psychological/ |
||||||||||||||||||||
In a pilot study that assessed the psychomotor performance of 46 men and women living with HIV, Vance, Smith, Neidig, and Weaver (2008) found an association between anger and psychomotor impairment on Trails A and the Grooved Pegboard for non-dominant hand, neuropsychological tests commonly used to assess cognitive performance among persons living with HIV. The investigators reason that "interventions that focus on anger management could have a therapeutic effect on psychomotor performance" (p. 93). Adherence to Treatment Active substance use has the potential to affect antiretroviral adherence negatively. To understand better the associations among correlates of schedule adherence (i.e., the percentage of antiretrovirals taken on time), Atkinson, Nilsson Schönnesson, Williams, and Timpson (2008) "developed an exploratory path model of schedule adherence" (p. 260) with data from a sample of 130 African American crack cocaine users who were living with HIV and prescribed HAART. Atkinson and colleagues found that "the effects of psychological distress on schedule adherence were mediated by patients' relationship with their doctor and optimism towards antiretroviral treatment. Adherence was also associated with patients' self-efficacy regarding their medical regimen which, in turn, was associated with their social support" (p. 260). In the view of these investigators,
Nurses, too, can benefit from such training, as demonstrated by DiIorio et al. (2008). She and her colleagues randomly assigned 247 low-income, primarily African American recipients of HIV care in Atlanta to one of two conditions: five sessions of motivational interviewing (MI) delivered by registered nurses in one-to-one counseling sessions over a 3-month period ("Get Busy Living")4 or a care-as-usual control condition. All study participants were either initiating ART or changing their antiretroviral treatment regimen. The MI intervention "sought to build confidence, reduce ambivalence and increase motivation for ART medication-taking.5 Medication adherence was measured by the Medication Event Monitoring System (MEMS®) from the time of screening until the final follow-up conducted approximately 12 months following the baseline assessment" (p. 273). DiIorio and colleagues found that
Depression can also negatively affect antiretroviral adherence. On this point, Horberg et al. (2008) reviewed data from a cohort of patients seen for HIV medical care in two large health maintenance organizations who were initiating a new HAART regimen. In total,
Horberg and colleagues emphasize that, "[b]ecause depression is negatively associated with HAART adherence and with clinical outcome measures for these patients, ... screening for depression is essential. ... Patients who are found to be depressed should be offered therapy, because compliant SSRI medication use was associated with improved HAART adherence and HIV laboratory parameters" (p. 389). Similarly, Vranceanu et al. (2008)
The investigators analyzed available data from 156 adults living with HIV that were taken at five time points, yielding a total of 444 data points. Vranceanu and colleagues found that
Vranceanu and colleagues suggest that the results of this study
Finally, Koenig et al. (2008) used a randomized controlled design to examine "whether persons who participated in ... [a clinic-based multicomponent social support] intervention7 achieved and maintained better adherence, and subsequently had better virologic outcomes, in the first 6 months of therapy compared with those who received standard-of-care adherence counseling" (p. 161). Two components of the intervention merit specific mention:
Importantly,
In other words, "[d]espite the efficacy of the intervention on adherence, and the significant association between sustained adherence and viral suppression, the intervention was not consistently associated with improved health outcomes. Specifically, whereas a larger proportion of those randomized to the intervention had undetectable viral loads, the effect of intervention was not statistically significant when considering just those who remained on-study" (p. 167). These findings prompt Koenig and colleagues to observe that "[e]arly discontinuation of care and treatment may be a greater threat to the health of HIV patients than imperfect medication-taking" (p. 159). Coping, Social Support, & Quality of Life Polzer Casarez and Miles (2008) explored spiritual coping through interviews with 38 African American mothers living with HIV in the southern United States and found that the "women dealt with the stresses of HIV through a relationship with God" (p. 118). These mothers, who had a child who was also living with HIV,
The investigators make a point of noting that "[m]others' participation in their relationship with God mostly focused on their own internal spiritual practices. However, some also discussed church attendance as an important spiritual practice and source of support. On the other hand, a number of mothers voiced reluctance to attend church due to fear of disclosure of their HIV status and the stigma, or because of negative attitudes of church members about people with HIV" (p. 128). Polzer Casarez and Miles urge clinicians who are "working with mothers with HIV to acknowledge their spirituality and assess how spirituality helps them cope with and manage their illness" (p. 118).8 Among women for whom spiritual beliefs and/or practices contribute to self-care and coping with HIV, "in-depth exploration could focus on specifics of her spiritual practices, her views about how spirituality helps, and how the ... [clinician] might support her spiritually. Sensitive probing might also reveal dilemmas the woman faces regarding church attendance and related concerns about stigma and disclosure[.] ... Helping women express concerns about the stigma related to HIV and problem-solving ways to manage these concerns is important" (pp. 129-130). Murphy and Marelich (2008) investigated resiliency – "the capacity for successful adaptation despite challenging circumstances" (p. 284) – among 111 well children between the ages of 6 and 11 years whose mothers were living with HIV disease. Mothers and their children were assessed at four time points: baseline, 6 months, 12 months, and 18 months. Murphy and Marelich found that
Murphy and Marelich are quick to note, however, that
Although countless studies have examined the influence of stress, coping, and depression on HIV disease progression, far less attention has been paid to the contribution of personality characteristics to the advancement of HIV disease. To address this gap in research, Ironson, O'Cleirigh, Weiss, Schneiderman, and Costa (2008) monitored a diverse sample of 104 men and women living with HIV disease over a 4-year period. Their purpose was to examine how the Five-Factor Model or the "Big Five" personality domains (Neuroticism [N], Extraversion [E], Openness [O], Agreeableness [A], Conscientiousness [C]) and their respective facets9 and profiles are related to changes in CD4 cell count and viral load. Ironson and colleagues found that the domains of O, E, and C were significantly associated with slower disease progression over the 4-year period, "controlling for age, education, gender, race, initial disease status, and antiretroviral medications" (p. 251). Delving more deeply,
Importantly, this study "did not account for psychiatric disorders in the sample nor were psychotropic medications included in the analysis. It is possible that acute psychiatric disturbances or their treatment may have biased the personality assessment. Similarly, the absence of neuropsychological assessment or physician assessed hepatitis C allows for the possibility that unidentified cognitive impairments or co-occurring liver disease may have unduly influenced some of the relationships reported here" (p. 251). Speaking to the importance of these findings, Ironson and colleagues point out that these
---- Compiled by Abraham Feingold, Psy.D. 4 "The majority (approximately 80%) of the sessions were held in person and lasted on average between 20 and 90 minutes[,] with a median of 45, 32 and 30 minutes for sessions 1, 2 and 3-5, respectively. Session 1 was completed in-person for all participants. Telephone sessions (for sessions 2-5) were conducted as needed for participants who were unable to meet the counsellor in the clinic. For sessions 2-5, 17%, 21%, 15% and 16% were completed via telephone. ... Participants were paid $10 for completing the first MI session and $5 for each of the remaining four sessions. In addition to the five MI sessions, participants in the intervention group received a copy of the Get Busy Living video, a journal and a calendar" (p. 275). 5 See the Tool Box on "Emerging Methods for Motivating Effective Medication Practice" in the Summer 2006 issue of mental health AIDS for more information on the application of MI to antiretroviral medication-taking. 6 "The SPAN ... is an abbreviated form of the widely used Davidson Trauma Scale ... and is a reliable and valid screening tool for PTSD ... . It has four items measuring startle, physiological arousal, anger, and numbness" (p. 316). "The PC-SAD is a reliable and valid tool for assessing depression in the primary care setting. ... The PC-SAD is a 37-item DSM-IV-compatible depression screening. ... It does not overlap with somatic symptoms of HIV infection" (p. 316). 7 "The intervention involved five sessions with ... [a] nurse-interventionist delivered just prior to and during the first 2 months following dispensing of medication. Two of these sessions occurred before the dispensing of medication (7-14 days apart), and three sessions occurred following medication dispensing (at Weeks 2, 4, and 8). In addition, there was also a session at 6 months. ... Support partners were welcome at all sessions, but were required to attend at least one of the first two sessions and two of the first four. Participants were also contacted by phone five times between intervention sessions: at Weeks 1, 6, and 10 and at Months 4 and 5 after beginning medications. In addition, participants were required to attend at least two of six group educational sessions at any time during the intervention. ... The first two sessions typically lasted 2 to 3 hours, depending on how much the patient already understood about HIV disease and antiretroviral medications; Sessions 3 through 6 typically lasted about 1.5 hours, ranging from 45 min to 2 hours" (pp. 161-162). 8 See the Tool Box on "All That Is Sacred: A Primer on Spiritual Assessment" in the Spring 2007 issue of mental health AIDS for information on a two-stage spiritual assessment process. 9 The personality domains measured by the Revised NEO Personality Inventory (NEO-PI-R), and their respective facet scales, are as follows: Neuroticism (Anxiety, Angry Hostility, Depression, Self-Consciousness, Impulsiveness, Vulnerability); Extraversion (Warmth, Gregariousness, Assertiveness, Activity, Excitement Seeking, Positive Emotions); Openness (Fantasy, Aesthetics, Feelings, Actions, Ideas, Values); Agreeableness (Trust, Straightforwardness, Altruism, Compliance, Modesty, Tender-Mindedness); Conscientiousness (Competence, Order, Dutifulness, Achievement Striving, Self-Discipline, Deliberation). "Interpretation on the domain level yields a rapid understanding of the individual, while interpretation of specific facet scales gives a more detailed assessment" (Costa & McCrae, 1995, p. 21). |
|
|||||||||||||||||||
|
| |